Olympus Expands Pediatric Bronchoscopy Portfolio with FDA Clearance for Two Single-Use Scopes — Olympus Corporation of the Americas (Olympus America Inc.)

Event summary

Olympus received FDA 510(k) clearance for pediatric use of two single-use bronchoscopes on February 24, 2026.
The Zero BCV1-02 model (2.2mm distal end) is approved for ages 6 months to 6 years.
The Slim BCV1-C2 model (3.2mm distal end) is approved for ages 6 years and older.
Bronchoscopes are manufactured by Vathin Medical and distributed exclusively by Olympus America Inc.
Devices feature 90° rotation, 210° angulation, and passive bending for enhanced maneuverability.

The big picture

This FDA clearance expands Olympus' position in the growing single-use endoscopy market, particularly in pediatric care where specialized equipment is critical. The clearance comes as hospitals increasingly seek infection-control solutions post-pandemic, potentially accelerating demand for single-use devices. Olympus' exclusive distribution agreement with Vathin Medical strengthens its respiratory portfolio while maintaining supply chain control.

What we're watching

Market Adoption: How quickly pediatric hospitals and clinics will integrate these specialized bronchoscopes into their workflows.
Competitive Response: Whether competitors will accelerate development of their own pediatric bronchoscopy solutions.
Revenue Impact: The pace at which this clearance will contribute to Olympus' respiratory division growth.